Deadline danger looms for manufacturers of combination and borderline products
This article was originally published in Clinica
Executive Summary
Manufacturers of drug and device combinations, or products on the drug/device borderline, are in danger of failing to meet the deadline for the European Union's Medical Devices Directive (MDD).